Orentas RJ - Search Results

1

Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen.

Zheng J, Kohler ME, Chen Q, Weber J, Khan J, Johnson BD, Orentas RJ. Zheng J, et al. Among authors: orentas rj. BMC Immunol. 2007 Mar 30;8:4. doi: 10.1186/1471-2172-8-4. BMC Immunol. 2007. PMID: 17397536 Free PMC article.

2

Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR.

Ritmeester-Loy SA, Draper IH, Bueter EC, Lautz JD, Zhang-Wong Y, Gustafson JA, Wilson AL, Lin C, Gafken PR, Jensen MC, Orentas R, Smith SEP. Ritmeester-Loy SA, et al. Sci Signal. 2024 Mar 5;17(826):eadd4671. doi: 10.1126/scisignal.add4671. Epub 2024 Mar 5. Sci Signal. 2024. PMID: 38442200 Free PMC article.

3

Nothing about us without us: Advocacy and engagement in genetic medicine.

Olayiwola O, Castillejo A, Louella M, Supercharger M, Harlow E, Dee L, Abdallah K, Kityo-Mutuluuza C, Adair JE, Orentas R, Dubé K. Olayiwola O, et al. Sci Transl Med. 2024 May 8;16(746):eadn2401. doi: 10.1126/scitranslmed.adn2401. Epub 2024 May 8. Sci Transl Med. 2024. PMID: 38718133

4

Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine.

Orentas RJ, Schauer D, Bin Q, Johnson BD. Orentas RJ, et al. Cell Immunol. 2001 Oct 10;213(1):4-13. doi: 10.1006/cimm.2001.1864. Cell Immunol. 2001. PMID: 11747351

5

Production of macrophage migration inhibitory factor by human and murine neuroblastoma.

Bin Q, Johnson BD, Schauer DW, Casper JT, Orentas RJ. Bin Q, et al. Among authors: orentas rj. Tumour Biol. 2002 May-Jun;23(3):123-9. doi: 10.1159/000064028. Tumour Biol. 2002. PMID: 12218292

6

Dual expression of CD80 and CD86 produces a tumor vaccine superior to single expression of either molecule.

Johnson BD, Yan X, Schauer DW, Orentas RJ. Johnson BD, et al. Among authors: orentas rj. Cell Immunol. 2003 Mar;222(1):15-26. doi: 10.1016/s0008-8749(03)00079-0. Cell Immunol. 2003. PMID: 12798304

7

Retroviral transfer of T-cell receptor genes produces cells with a broad range of lytic activity.

Orentas RJ, Bircher LA, Roskopf S. Orentas RJ, et al. Scand J Immunol. 2003 Jul;58(1):33-42. doi: 10.1046/j.1365-3083.2003.01277.x. Scand J Immunol. 2003. PMID: 12828556 Free PMC article.

8

CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance.

Rosenblum MD, Olasz E, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Orentas RJ, Sandford G, Truitt RL. Rosenblum MD, et al. Among authors: orentas rj. Blood. 2004 Apr 1;103(7):2691-8. doi: 10.1182/blood-2003-09-3184. Epub 2003 Nov 26. Blood. 2004. PMID: 14644999 Free article.

9

Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo.

Yan X, Johnson BD, Orentas RJ. Yan X, et al. Among authors: orentas rj. Immunology. 2004 May;112(1):105-16. doi: 10.1111/j.1365-2567.2004.01853.x. Immunology. 2004. PMID: 15096190 Free PMC article.

10

Immediate transfection of patient-derived leukemia: a novel source for generating cell-based vaccines.

Gershan JA, Johnson BD, Weber J, Schauer DW, Natalia N, Behnke S, Burns K, Maloney KW, Warwick AB, Orentas RJ. Gershan JA, et al. Among authors: orentas rj. Genet Vaccines Ther. 2005 Jun 21;3(1):4. doi: 10.1186/1479-0556-3-4. Genet Vaccines Ther. 2005. PMID: 15969754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters